FindTrial
Sign In

The clinically proven of HPV E6/E7 mRNA detection

The clinically proven of HPV E6/E7 mRNA detection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-13003730
Enrollment
Unknown
Registered
2013-10-22
Start date
2013-10-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Interventions

Gold Standard:
Index test:

Sponsors

KODIA (XINXIANG) BIOTECHNOLOGY INC.
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Formalin-fixed paraffin-embedded (FFPE) cervical samples

Exclusion criteria

Exclusion criteria: 1. due to vulvar cancer, cervical cancer, endometrial cancer and other malignancies after pelvic external beam radiotherapy close and patient specimens; 2. confirms merger vaginal cancer, vulvar cancer patients cervical specimens.

Design outcomes

Primary

MeasureTime frame
The copy levels of HPV E6/E7 mRNA;—

Contacts

Public ContactLU LUZHANG

KODIA (XINXIANG) BIOTECHNOLOGY INC.

llz@yhkodia.com+86 18106066909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026